Ran Nussbaum Insider Trading $KITE Kite Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ran Nussbaum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is Director in ARQULE INC ($ARQL) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Kite Pharma, Inc. ($KITE) and Director in Keros Therapeutics, Inc. ($KROS) and Director in UroGen Pharma Ltd. ($URGN) and Director in Prevail Therapeutics Inc. ($PRVL).
Ran Nussbaum in Kite Pharma, Inc.
Trading Symbol: KITEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ran Nussbaum in Kite Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | D | 0.00 | 2,632 | 0 | 0 | 2.6 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | D | 0.00 | 1,029 | 0 | 0 | 1 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | D | 0.00 | 2,651 | 0 | 0 | 2.7 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | D | 0.00 | 3,520 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | D | 0.00 | 4,360 | 0 | 0 | 4.4 K to 0 (-100.00 %) |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
May 11 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | P | 68.94 | 2,632 | 181,450 | 2,632 | 0 to 2.6 K |
May 11 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | P | 69.17 | 1,029 | 71,176 | 1,029 | 0 to 1 K |
May 11 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | P | 69.17 | 2,651 | 183,370 | 2,651 | 0 to 2.7 K |
May 11 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | P | 69.17 | 3,520 | 243,478 | 3,520 | 0 to 3.5 K |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Grant | A | 0.00 | 1,950 | 0 | 1,950 | 0 to 2 K |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 | |
Jun 03 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 56.08 | 24,070 | 1,349,846 | 0 | 24.1 K to 0 (-100.00 %) |
Jun 03 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 55.27 | 200,604 | 11,087,383 | 24,070 | 224.7 K to 24.1 K (-89.29 %) |
Jun 03 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 57.38 | 7,800 | 447,564 | 224,674 | 232.5 K to 224.7 K (-3.36 %) |
Jun 03 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 56.44 | 3,754 | 211,876 | 232,474 | 236.2 K to 232.5 K (-1.59 %) |
Jun 03 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 55.05 | 69,206 | 3,809,790 | 236,228 | 305.4 K to 236.2 K (-22.66 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 59.91 | 25,560 | 1,531,404 | 43,604 | 69.2 K to 43.6 K (-36.96 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 59.91 | 23,349 | 1,398,934 | 112,714 | 136.1 K to 112.7 K (-17.16 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 59.91 | 66,948 | 4,011,129 | 149,116 | 216.1 K to 149.1 K (-30.99 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 61.24 | 50,000 | 3,062,050 | 70,000 | 120 K to 70 K (-41.67 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 61.24 | 13,937 | 853,516 | 136,063 | 150 K to 136.1 K (-9.29 %) |
Mar 31 2015 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Sell | S | 61.24 | 13,936 | 853,455 | 216,064 | 230 K to 216.1 K (-6.06 %) |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 313,531 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 807,681 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 1,072,245 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 314,743 | 0 | 314,743 | 0 to 314.7 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 810,803 | 0 | 810,803 | 0 to 810.8 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 1,076,390 | 0 | 1,076,390 | 0 to 1.1 M |
Page: 1